Sandbox Reserved 987: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Cocaine Esterase==
<Structure load='4P08' size='400' frame ='true' align='right' caption='Cocaine Esterase' scene='69/691529/Cocaineesterase/1' />
<Structure load='4P08' size='400' frame ='true' align='right' caption='Cocaine Esterase' scene='69/691529/Cocaineesterase/1' />


Line 38: Line 36:


== Mutations ==
== Mutations ==
The wild-type cocaine esterase is not stable at physiological temperature, which poses a problem for its use as a pharmaceutical drug. Mutations have been conducted in order to increase its thermostability. In vivo testing showed the wild-type having a 11 min half-life. A mutant having its threonine swapped for a arginine at position 172 was found to last 9 times as long, and a mutant that further had its glycine swapped for a glutamine was found to last 24 times as long (~4hr 20min)<sup><ref>Gao D., Narasimhan D. L., Macdonald J., Brim R., Ko M., Landry D. W., Woods J. H., Sunahara R. K., Zhan C. (2009) Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol. Pharmacol. 75, 318-323.</ref></sup>
The wild-type cocaine esterase is not stable at physiological temperature, which poses a problem for its use as a pharmaceutical drug. Mutations have been conducted in order to increase its thermostability. In vivo testing showed the wild-type having a 11 min half-life. A mutant having its threonine swapped for a arginine at position 172 (T172R) was found to last 9 times as long, and a mutant that further had its glycine swapped for a glutamine (T172R/G173Q) was found to last 24 times as long (~4h 20m)<sup><ref>Gao D., Narasimhan D. L., Macdonald J., Brim R., Ko M., Landry D. W., Woods J. H., Sunahara R. K., Zhan C. (2009) Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol. Pharmacol. 75, 318-323.</ref></sup> Another mutant that has been explored is the L169K/G173Q mutant. This showed an in vivo half life of ~2h 20m.<sup><ref>Brim R. L., Nance M. R., Youngstrom D. W., Narasimhan D., Zhan C. G., Tesmer J. J. G., Sunahara, R. K., Woods J. W. (2010) A Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine Abuse. Mol. Pharmacol. 77(4), 593-600.</ref></sup> L169K causes a large increase in half life up to 9h 30m, but reduced catalytic efficiency 4.5 fold.<sup><ref>Narasimhan D., Nance M.R., Gao D., Ko M.C., Macdonald J., Tamburi P., Yoon D., Landry D.M., Woods J.H., Zhan C.G., Tesmer J.J., Sunahara R.K. (2009) Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Eng. Des. Sel. 23:537-547.</ref></sup>


== Medical Relevance ==
== Medical Relevance ==


Cocaine is a tropane alkaloid produced by the South American plant Erythroxylon coca.<sup><ref>Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol. Toxicol. 1993; 72(1): 3–12. [PubMed: 8441738]</ref></sup> Cocaine’s psychological effects occur via binding to neurotransmitter reuptake transporters in the presynaptic nerve termini and blocking them, leading to prolonged presence of neurotransmitters in the synapse.<sup><ref>Johanson CE, Fischman MW. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989; 41(1):3–52. [PubMed: 2682679]</ref></sup> Large amounts of dopamine and serotonin in the synapse results in feelings of euphoria and wellbeing. This lingering increase in neurotransmitters within the synapse can lead to self-administration and, therefore, addiction. When cocaine is bound to noradrenergic transporters, elevated noradrenergic signaling occurs, resulting in increased heart rate (HR), blood pressure and vasoconstriction which are often seen in cocaine users.<sup><ref>Crumb WJ Jr, Kadowitz PJ, Xu YQ, Clarkson CW. Electrocardiographic evidence for cocaine cardiotoxicity in cat. Can. J. Physiol. Pharmacol. 1990; 68(5):622–625. [PubMed: 2340451]</ref></sup> Cocaine also binds cardiac and neuronal sodium channels leading to profound cardiovascular and central nervous system alterations that are frequently lethal.<sup><ref>Zimmerman JL. Cocaine intoxication. Crit Care Clin 2012; 28: 517–526</ref></sup> Cocaine abuse is a serious public health problem. 50% of emergency room visits are due to illicit drug use, cocaine accounts for the majority of those cases.<sup><ref>Ball, JK.; Albright, V. National Estimates of Drug-Related Emergency Department Visits. Rockville, MD, USA: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008</ref></sup> Interestingly, despite cocaine’s broad use and high addictiveness, there is no US FDA-approved medication for the treatment of cocaine abuse or toxicity. Physicians treat patients enduring cocaine toxicity with standard emergency room agents that control arrhythmias, convulsions and high blood pressure but not with drugs that directly address the toxic levels of cocaine present in the patient.
Cocaine is a tropane alkaloid produced by the South American plant Erythroxylon coca.<sup><ref>Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol. Toxicol. 1993; 72(1): 3–12. [PubMed: 8441738]</ref></sup> Cocaine’s psychological effects occur via binding to neurotransmitter reuptake transporters in the presynaptic nerve termini and blocking them, leading to prolonged presence of neurotransmitters in the synapse.<sup><ref>Johanson CE, Fischman MW. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989; 41(1):3–52. [PubMed: 2682679]</ref></sup> Large amounts of dopamine and serotonin in the synapse results in feelings of euphoria and wellbeing. This lingering increase in neurotransmitters within the synapse can lead to self-administration and, therefore, addiction. When cocaine is bound to noradrenergic transporters, elevated noradrenergic signaling occurs, resulting in increased heart rate (HR), blood pressure and vasoconstriction which are often seen in cocaine users.<sup><ref>Crumb WJ Jr, Kadowitz PJ, Xu YQ, Clarkson CW. Electrocardiographic evidence for cocaine cardiotoxicity in cat. Can. J. Physiol. Pharmacol. 1990; 68(5):622–625. [PubMed: 2340451]</ref></sup> Cocaine also binds cardiac and neuronal sodium channels leading to profound cardiovascular and central nervous system alterations that are frequently lethal.<sup><ref>Zimmerman JL. Cocaine intoxication. Crit Care Clin 2012; 28: 517–526</ref></sup> Cocaine abuse is a serious public health problem. 50% of emergency room visits are due to illicit drug use, cocaine accounts for the majority of those cases.<sup><ref>Ball, JK.; Albright, V. National Estimates of Drug-Related Emergency Department Visits. Rockville, MD, USA: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008</ref></sup> Interestingly, despite cocaine’s broad use and addictive effects, there is no US FDA-approved medication for the treatment of cocaine abuse or toxicity. Physicians treat patients enduring cocaine toxicity with standard emergency room agents that control arrhythmias, convulsions and high blood pressure but not with drugs that directly address the toxic levels of cocaine present in the patient.


Finding a therapeutic agent to combat cocaine, such as small molecules has proven difficult. For this reason, the focus has been switched to cocaine esterases. For over a decade, cocaine esterases have been studied and numerous findings strongly suggest that bacterial cocaine esterases should provide a safe and effective method to rapidly eliminate the symptoms of acute cocaine intoxication in humans, as well as reducing addictiveness to the drug.  
Finding a therapeutic agent to combat cocaine, such as small molecules has proven difficult. For this reason, the focus has been switched to cocaine esterases. For over a decade, cocaine esterases have been studied and numerous findings strongly suggest that bacterial cocaine esterases should provide a safe and effective method to rapidly eliminate the symptoms of acute cocaine intoxication in humans, as well as reducing addictiveness to the drug.